The Creation of Low Dose Medicine
Over 64,500 sq. ft. in area, the factory in Milan, Italy was officially opened on September 25th, 2008 to celebrate the company’s 25th anniversary.
The façade, a bold blend of light and colour, was designed by architect Ivo Pellegri, and was subsequently voted as the best European industrial facade. The garden in front of the building was designed by the artist Das, who created an innovative layout that combines water, sound, and plant life.
In a perfect fusion of tradition and modernity, the facility uses innovative technology to create a healthier environment.
Medicines, and medical devices, are produced here in accordance with GMP – Good Manufacturing Practices.
A structured Integrated Quality Management System compliant with the ISO 9001:2015 standard guarantees the conformity of our processes with international standards and the most stringent health, safety, and environmental regulations.
All raw materials, components, finished products, and packaging materials are subject to quality controls in order to monitor their compliance with these high standards.
Production begins with the starting materials, of animal, vegetable, or mineral origin as per the indications of the corresponding Pharmacopoeias. The starting materials are subject to the dilution procedures indicated by the European Pharmacopoeia. The dilution and dynamization process used in low dose medicines utilizes SKA (Sequential Kinetic Activation) technology, which is applied to the nano concentrations of active ingredients.
At our factory we produce oral medicines (granules, globules, drops, oral sprays, syrups) and nasal sprays. These materials undergo the chemical and microbiological processes required by international regulations.